Cognitive behavioral therapy vs. pharmacotherapy: a comparative study on managing generalised anxiety disorder

Generalized Anxiety Disorder (GAD) is a prevalent mental health condition characterized by persistent, excessive worry that significantly disrupts daily functioning. Effective management of GAD involves two primary therapeutic strategies: Cognitive Behavioral Therapy (CBT) and pharmacological intervention. CBT is a structured psychotherapeutic approach designed to modify dysfunctional thought patterns and behaviors contributing to anxiety, while pharmacotherapy primarily employs selective serotonin reuptake inhibitors (SSRIs) and benzodiazepines to alleviate symptoms. This analysis presents a comparative evaluation of both treatment modalities, focusing on their efficacy, long-term outcomes, adverse effects, and patient adherence. Evidence indicates that CBT provides sustainable therapeutic benefits by fostering skill acquisition, whereas pharmacotherapy offers rapid symptomatic relief, particularly beneficial in acute settings. The combined use of CBT and medication demonstrates synergistic effects, enhancing clinical outcomes and preventing relapse. This review aims to guide healthcare providers and patients in making informed treatment decisions based on individual symptom severity, therapeutic response, and patient preference. Further research is warranted to explore the long-term effectiveness of integrated treatment strategies across diverse patient populations to optimize care outcomes.